Movement Alert｜Veeva Falls 5.1% in Regular Trading, Health Care Technology Sector Broadly Under Pressure

Market Focus07-30

On July 30, Veeva fell 5.1% in regular trading, trading at $198.01/share, with turnover of $79.58 million.

The decline was driven primarily by broad-based selling pressure across the Health Care Technology sector. Among peers, Teladoc Health plunged 27.72%, Waystar Holding dropped 16.15%, Doximity fell 5.09%, and Certara declined 2.35%, while VSee Health rose 6.43%.

On the company front, Veeva had recently received positive catalysts, including Guggenheim initiating coverage with a Buy rating on July 23, citing an average analyst price target of $241.04. The company's FY2027 Q1 earnings reported in early June were strong, with revenue of $882.9 million beating estimates and full-year adjusted EPS guidance raised to $9.05. Additionally, Veeva was added to the S&P 500 index in May. Despite these fundamental tailwinds, the stock was unable to resist sector-wide headwinds during the session.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1157573227?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-30 22:56","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1157573227","market":"us","top_or_hot":-1,"title":"Movement Alert｜Veeva Falls 5.1% in Regular Trading, Health Care Technology Sector Broadly Under Pressure","media":"Market Focus","content":"<p><p>On July 30, Veeva fell 5.1% in regular trading, trading at $198.01/share, with turnover of $79.58 million.</p><p>The decline was driven primarily by broad-based selling pressure across the Health Care Technology sector. Among peers, Teladoc Health plunged 27.72%, Waystar Holding dropped 16.15%, Doximity fell 5.09%, and Certara declined 2.35%, while VSee Health rose 6.43%.</p><p>On the company front, Veeva had recently received positive catalysts, including Guggenheim initiating coverage with a Buy rating on July 23, citing an average analyst price target of $241.04. The company's FY2027 Q1 earnings reported in early June were strong, with revenue of $882.9 million beating estimates and full-year adjusted EPS guidance raised to $9.05. Additionally, Veeva was added to the S&P 500 index in May. Despite these fundamental tailwinds, the stock was unable to resist sector-wide headwinds during the session.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Veeva Falls 5.1% in Regular Trading, Health Care Technology Sector Broadly Under Pressure</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Veeva Falls 5.1% in Regular Trading, Health Care Technology Sector Broadly Under Pressure\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-30 22:56</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 30, Veeva fell 5.1% in regular trading, trading at $198.01/share, with turnover of $79.58 million.</p><p>The decline was driven primarily by broad-based selling pressure across the Health Care Technology sector. Among peers, Teladoc Health plunged 27.72%, Waystar Holding dropped 16.15%, Doximity fell 5.09%, and Certara declined 2.35%, while VSee Health rose 6.43%.</p><p>On the company front, Veeva had recently received positive catalysts, including Guggenheim initiating coverage with a Buy rating on July 23, citing an average analyst price target of $241.04. The company's FY2027 Q1 earnings reported in early June were strong, with revenue of $882.9 million beating estimates and full-year adjusted EPS guidance raised to $9.05. Additionally, Veeva was added to the S&P 500 index in May. Despite these fundamental tailwinds, the stock was unable to resist sector-wide headwinds during the session.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"VEEV","symbol_name":"Veeva Systems Inc.","start_time":0,"source_url":"","article_id":"1157573227","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1157573227","pubTimestamp":1785423408,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 30, Veeva fell 5.1% in regular trading, trading at $198.01/share, with turnover of $79.58 million.The decline was driven primarily by broad-based selling pressure across the Health Care...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"VEEV":"Veeva Systems Inc."},"translate_title":"走势警报|Veeva 常规交易下跌 5.1%，医疗保健技术板块普遍承压","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VEEV":1},"content_text":"On July 30, Veeva fell 5.1% in regular trading, trading at $198.01/share, with turnover of $79.58 million.The decline was driven primarily by broad-based selling pressure across the Health Care Technology sector. Among peers, Teladoc Health plunged 27.72%, Waystar Holding dropped 16.15%, Doximity fell 5.09%, and Certara declined 2.35%, while VSee Health rose 6.43%.On the company front, Veeva had recently received positive catalysts, including Guggenheim initiating coverage with a Buy rating on July 23, citing an average analyst price target of $241.04. The company's FY2027 Q1 earnings reported in early June were strong, with revenue of $882.9 million beating estimates and full-year adjusted EPS guidance raised to $9.05. Additionally, Veeva was added to the S&P 500 index in May. Despite these fundamental tailwinds, the stock was unable to resist sector-wide headwinds during the session.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1157573227","isCrawlerRequest":true}